2024 Research: Global Invasive Ductal Carcinoma Treatment Market Set to Reach $23.02 Billion by 2034, - Rising Prevalence of Breast Cancer Fuels Advancements in Personalized Medicine
27 janv. 2025 04h29 HE
|
Research and Markets
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Invasive Ductal Carcinoma Treatment Market by Therapy, by Type, by Distribution Channel, and By Region" report has been added to ...
Oncology Based in-Vivo CRO Business Research Report 2024: Global Market to Reach $2.5 Billion by 2030 - Expansion in Drug Discovery, Translational Research, and Toxicology Fuels Growth
09 janv. 2025 04h01 HE
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Oncology Based in-Vivo CRO - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Oncology-Based In-Vivo CRO Market Projected for Vigorous Growth, North America Leads Regional Shares
07 mars 2024 12h09 HE
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Oncology-based In-Vivo CRO Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Industry Anticipates Major...
American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis
22 févr. 2024 08h00 HE
|
Bionano Genomics
SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that optical genome mapping (OGM) was included for the first time in the American College of...
Immuno-oncology Clinical Trials Market Poised for Remarkable Growth, with USD 12.87 Billion Forecasted by 2030
24 janv. 2024 08h54 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Immuno-oncology Clinical Trials Market by Design (Expanded Access Trials, Interventional Trials, Observational Trials), Phase (Phase I, Phase...
Anti-Cancer Monoclonal Antibodies Market to Reach $95.99 billion by 2028, with Asia Pacific Emerging as Fastest-Growing Region
22 janv. 2024 21h08 HE
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Anti-Cancer MAbS Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The Anti-Cancer Monoclonal Antibodies (MAbs)...
Oncology Based In-Vivo CRO Industry Experiences Surge with Innovative Solutions: Global Market Report 2023 Explores Trends and Growth Factors
11 déc. 2023 04h28 HE
|
Research and Markets
Dublin, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The "Oncology Based In-Vivo CRO Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global market for...
Cellectis Presents Pre-Clinical Data on Multi-armored Allogeneic MUC1-CAR T-cells Targeting Triple-Negative Breast Cancer at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
31 oct. 2023 16h30 HE
|
Cellectis Inc.
NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
Machine Learning Model Unveils Stunning Lung Cancer Risk Predictions
05 oct. 2023 11h58 HE
|
Research and Markets
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- In a recent groundbreaking study published on October 3rd in the open access journal PLOS Medicine, Thomas Callender of University College London and his...
Global Minimal Residual Disease (MRD) Market Size to Reach USD 4,138.5 Million in 2030 | Emergen Research
14 sept. 2023 09h51 HE
|
Emergen Research
Vancouver, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The global Minimal Residual Disease (MRD) market size was USD 1,095.3 Million in 2021 and is expected to register a revenue CAGR of 16.04% during the...